$ITGR

Integer Holdings Agrees To Be Acquired By KKR For $127/Share

Integer Holdings Corp. agreed to be acquired by an affiliate of KKR & Co. in an all-cash deal valued at about $5.7 billion enterprise value. Integer shareholders will receive $127 per share. The deal is expected to close by year-end, after which Integer will be privately held and delisted from the NYSE. KKR shares were about $102.60 premarket.

Original reporting
Published Aug 3, 2026, 11:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 3, 2026, 12:22 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefMergers & acquisitions
Primary signal
$ITGR
Bullish
high confidence
Mentioned
$ITGR
Relevance
9/10
alphai data visualization · based on rttnews.com
Decision brief

The 30-second read

$ITGRBullishHigh
01

Why it matters

For traders, the actionable element is the fixed all-cash price ($127/share) versus the current pre-market reference ($102.60 for KKR in the article, though not ITGR), implying a takeover spread and a timeline to year-end closing.

02

Market read

A new, all-cash take-private deal with a stated per-share price and year-end close expectation typically drives immediate repricing and takeover-arb positioning.

03

What to watch

The article does not specify regulatory approvals, financing certainty, or any termination fees, which can materially affect closing odds and the post-announcement trading path.

Relevance 9/10Novelty 9/10Timing: deal announced pre-market today, with expected close by end of year

Background

Integer Holdings will become privately held under an acquisition by a KKR affiliate, with its NYSE listing ending upon completion.

Company-level read

Ticker impact

$ITGRBullishHigh confidence
Context

Integer Holdings agreed to be acquired by KKR in an all-cash deal at $127 per share, taking it private and delisting from NYSE.

Expected impact

Expect ITGR to trade toward the $127 offer price with volatility around deal mechanics, regulatory/closing conditions, and any competing bids.

Evidence & confidence

The article discloses the key deal terms: all-cash consideration ($127/share), enterprise value (~$5.7B), unanimous board approval, and expected close by year-end, which typically drives price convergence toward the offer.

Market effects

Could modestly lift sentiment for acquisition targets in the same industrial/tech-adjacent ecosystem, but the article is company-specific.

Primarily US-listed takeover dynamics; limited direct regional spillover beyond US small/mid-cap M&A sentiment.

KKR is global, but the disclosed event is a single-company transaction with limited direct global macro linkage.

Counterpoint

Offer-price convergence can fail if closing conditions deteriorate, so spread trades should account for deal-break risk rather than assuming certainty.

Key entities

  • Integer Holdings Corp.

    Subject of the acquisition agreement, receiving $127 per share in an all-cash transaction.

  • KKR & Co. Inc.

    Investment funds managed by KKR will acquire Integer via an affiliate.

Related articles

$ITGRHighAI 9/10

What Integer's Deal Means for Minnesota's Med Device Industry

Integer Holdings, a major medical device manufacturer, is being acquired by KKR for $5.7B. Integer supplies components to companies like Abbott, Boston Scientific, and Medtronic. The deal may impact Minnesota's med-tech industry, where Integer has significant operations. KKR's acquisition could lead to consolidation in the sector, with potential implications for competition and pricing. Integer reported $1.8B in revenue last year.

$KKRHighAI 9/10

KKR to Acquire Integer Holdings in $5.7 Bn All-Cash Deal

KKR will acquire medical device outsourcing company Integer Holdings in an all-cash deal valued at about $5.7 billion, paying $127 per share and assuming Integer’s outstanding debt, according to the companies. The offer implies a 4.78% premium to Integer’s Friday close. Integer shares rose 2.4% premarket. KKR said it will expand its healthcare portfolio.

$SUPNMed

Biotech funding rises 75% year-over-year, Braveheart surges

Macquarie said global biotech funding for the year through Aug. 7 rose 75% YoY, driven by IPOs up 235% and follow-ons up 138%. The XBI biotech index gained 7% in the week to Aug. 7. Braveheart Bio’s upsized IPO raised $382.5M and shares jumped 66%. Curium agreed to buy Lantheus for up to $8B, and Supernus and Indivior plan an all-stock merger.

$KKRHighAI 9/10

KKR to take Integer private for $5.7B

KKR agreed to buy Integer Holdings for about $5.7B in an all-cash deal, taking Integer private. The transaction is expected to close before year-end, subject to regulatory approvals and shareholder support. Integer stockholders would receive about $127 per share, a 51%+ premium to April 29. Integer reported $464M Q2 sales, down 2.6%.